Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-017423
Filing Date
2019-11-14
Accepted
2019-11-14 15:49:02
Documents
38
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 296087
2 ex10-1.htm EX-10.1 1247
3 ex10-2.htm EX-10.2 1316
4 ex31-1.htm EX-31.1 17996
5 ex31-2.htm EX-31.2 17937
6 ex32-1.htm EX-32.1 8090
7 logo.jpg GRAPHIC 4447
8 ex10-1_001.jpg GRAPHIC 525889
9 ex10-2_002.jpg GRAPHIC 587806
  Complete submission text file 0001493152-19-017423.txt   2657908

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE vapa-20190930.xml EX-101.INS 92024
11 XBRL SCHEMA FILE vapa-20190930.xsd EX-101.SCH 12701
12 XBRL CALCULATION FILE vapa-20190930_cal.xml EX-101.CAL 21951
13 XBRL DEFINITION FILE vapa-20190930_def.xml EX-101.DEF 44132
14 XBRL LABEL FILE vapa-20190930_lab.xml EX-101.LAB 101335
15 XBRL PRESENTATION FILE vapa-20190930_pre.xml EX-101.PRE 85699
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
VapAria Corp (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55470 | Film No.: 191219695
SIC: 2834 Pharmaceutical Preparations